Biotech

All Articles

Galapagos stops CAR-T tissue treatment litigation over Parkinsonism case

.Galapagos has actually paused registration in a trial of a BCMA-directed CAR-T tissue treatment, pu...

James Wilson leaving Penn to release two brand-new biotechs

.After greater than 30 years, genetics therapy pioneer James Wilson M.D., Ph.D., is actually leaving...

3 biotechs try to defeat the summer months warm through losing personnel

.As biotechs seek to transform a fresh web page in August, at the very least 3 firms have dropped pe...

venBio elevates $528M for 5th lifestyle sciences VC fund

.Veteran equity capital agency venBio has raised another half a billion dollars to acquire biotechs ...

Otsuka pays $800M for Jnana as well as its own clinical-stage PKU drug

.Otsuka Drug has actually grabbed Boston-based Jnana Therapeutics for $800 million so the Japanese b...

FibroGen gives up 75% of US staff as asset flunks 2 more tests

.FibroGen is actually radically reorganizing its own business, giving up 75% of its U.S. team and al...

Tracon relax weeks after injectable PD-L1 inhibitor stop working

.Tracon Pharmaceuticals has actually chosen to unwind procedures weeks after an injectable immune ch...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is actually wagering $400 million in biobucks that a bispecific antibody-drug co...

Takeda takes $140M reduction on neglected epilepsy drug, boasts FDA operate

.Our company already recognize that Takeda is intending to locate a course to the FDA for epilepsy m...

VBI Vaccines apply for bankruptcy, looks for property purchase

.Immunology biotech VBI Injections is actually drifting hazardously near to the moment of truth, alo...